Patents by Inventor Bertrand Villet

Bertrand Villet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11027010
    Abstract: The invention relates to grass pollen extracts containing reduced amount of flavonoid glycosides in order to minimize the risks of genotoxicity of the grass pollen extracts. The invention also relates to a method of preparing grass pollen extracts containing reduced amount of flavonoid glycosides by ultrafiltration. Flavonoid glycosides are naturally present in grass pollen extracts and they have been identified as being responsible for the formation of flavonoid aglycones, which are genotoxic in vitro, under the influence of enzymes contained in the grass pollen extracts.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: June 8, 2021
    Assignee: STALLERGENES
    Inventors: Philippe Moingeon, Thierry Batard, Bertrand Villet
  • Patent number: 9795644
    Abstract: The invention relates to grass pollen extracts containing reduced amount of flavonoid glycosides in order to minimize the risks of genotoxicity of the grass pollen extracts. The invention also relates to a method of preparing grass pollen extracts containing reduced amount of flavonoid glycosides by ultrafiltration. Flavonoid glycosides are naturally present in grass pollen extracts and they have been identified as being responsible for the formation of flavonoid aglycones, which are genotoxic in vitro, under the influence of enzymes contained in the grass pollen extracts.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: October 24, 2017
    Assignee: STALLERGENES
    Inventors: Philippe Moingeon, Thierry Batard, Bertrand Villet
  • Publication number: 20170224810
    Abstract: The invention relates to grass pollen extracts containing reduced amount of flavonoid glycosides in order to minimize the risks of genotoxicity of the grass pollen extracts. The invention also relates to a method of preparing grass pollen extracts containing reduced amount of flavonoid glycosides by ultrafiltration. Flavonoid glycosides are naturally present in grass pollen extracts and they have been identified as being responsible for the formation of flavonoid aglycones, which are genotoxic in vitro, under the influence of enzymes contained in the grass pollen extracts.
    Type: Application
    Filed: January 26, 2017
    Publication date: August 10, 2017
    Inventors: Philippe MOINGEON, Thierry BATARD, Bertrand VILLET
  • Publication number: 20120148626
    Abstract: The invention relates to grass pollen extracts containing reduced amount of flavonoid glycosides in order to minimize the risks of genotoxicity of the grass pollen extracts. The invention also relates to a method of preparing grass pollen extracts containing reduced amount of flavonoid glycosides by ultrafiltration. Flavonoid glycosides are naturally present in grass pollen extracts and they have been identified as being responsible for the formation of flavonoid aglycones, which are genotoxic in vitro, under the influence of enzymes contained in the grass pollen extracts.
    Type: Application
    Filed: June 7, 2010
    Publication date: June 14, 2012
    Applicant: STALLERGENES S.A.
    Inventors: Philippe Moingeon, Thierry Batard, Bertrand Villet
  • Patent number: 7030104
    Abstract: The present invention relates to the field of therapeutic chemistry and more especially to the realization of new galenic forms intended to be applied on the skin. More particularly it relates to a topical hormonal composition with a systemic effect for the hormonal treatment of the perimenopause and of the menopause as well as for the treatment of the ovarian hormonal deficiencies in women with amenorrhea, characterized in that it comprises, as active ingredients, a progestogen derived from 19-nor progesterone and estradiol or one of its derivatives, a vehicle which allows the systemic passage of said active ingredients, chosen from the group constituted by a solubilizing agent, an absorption promoting agent, a film-forming agent, a gelling agent and their mixtures, in combination or in a mixture with suitable excipients for the realization of a gelled and/or film-forming pharmaceutical form.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: April 18, 2006
    Assignee: Laboratoire Theramex
    Inventors: Georges Gray, Bertrand Villet, Jacques Paris, Jean-Louis Thomas
  • Publication number: 20030181430
    Abstract: The present invention relates to the field of therapeutic chemistry and more especially to the realization of new galenic forms intended to be applied on the skin.
    Type: Application
    Filed: June 26, 2002
    Publication date: September 25, 2003
    Inventors: Georges Gray, Bertrand Villet, Jacques ` Paris, Jean-Louis Thomas